Most recently, the combination of OPN, TIMP-1 and CA 19-9 was found to be effective in the discrimination of patients with pancreatic cancer from a group of healthy controls and patients diagnosed with pancreatitis [9]. This evidence concerns the gene TIMP1 and pancreatic neoplasm.